PISCATAWAY, N.J.–(BUSINESS WIRE)–Genscript Biotech Corporation, the number one global provider of gene synthesis services and a strong player in synthetic biology, ended 2015 with a successful IPO on the Hong Kong exchange.
Source:: feeds.businesswire.com/click.phdo?i=45d8493952397c342b0b4a4412485c11